These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 28159816)

  • 41. [The results of SPRINT study from the point of nephrology].
    Monhart V
    Vnitr Lek; 2016; 62 Suppl 6():55-57. PubMed ID: 28124932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
    JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unobserved automated office BP is similar to other clinic BP measurements: A prospective randomized study.
    Papademetriou V; Tsioufis C; Chung A; Geladari C; Andreadis EA
    J Clin Hypertens (Greenwich); 2018 Oct; 20(10):1411-1416. PubMed ID: 30272388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Orthostatic changes in systolic blood pressure among SPRINT participants at baseline.
    Townsend RR; Chang TI; Cohen DL; Cushman WC; Evans GW; Glasser SP; Haley WE; Olney C; Oparil S; Del Pinto R; Pisoni R; Taylor AA; Umanath K; Wright JT; Yeboah J;
    J Am Soc Hypertens; 2016 Nov; 10(11):847-856. PubMed ID: 27665708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.
    Egan BM; Li J; Wagner CS
    Hypertension; 2016 Aug; 68(2):318-23. PubMed ID: 27354422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
    Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
    Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypertension and left ventricular hypertrophy in pediatric peritoneal dialysis patients: ambulatory blood pressure monitoring and echocardiographic evaluation.
    Ozçakar ZB; Yalçinkaya F; Tutar E; Cakar N; Uçar T; Elhan A; Acar B; Yüksel S; Uncu N; Kara N; Atalay S; Ekim M
    Nephron Clin Pract; 2006; 104(2):c101-6. PubMed ID: 16785736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy.
    Fagard RH; Staessen JA; Thijs L
    J Hypertens; 1997 Dec; 15(12 Pt 1):1493-502. PubMed ID: 9431857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.
    Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlates of systolic hypertension in patients with chronic kidney disease.
    Agarwal R; Andersen MJ
    Hypertension; 2005 Sep; 46(3):514-20. PubMed ID: 16103271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Should blood pressure goal be individualized in hypertensive patients?
    Yannoutsos A; Kheder-Elfekih R; Halimi JM; Safar ME; Blacher J
    Pharmacol Res; 2017 Apr; 118():53-63. PubMed ID: 27919826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
    Aggarwal R; Petrie B; Bala W; Chiu N
    Hypertension; 2019 Jun; 73(6):1275-1282. PubMed ID: 31067189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Office blood pressure and 24-hour ambulatory blood pressure measurements: high proportion of disagreement in resistant hypertension.
    Rodrigues CS; Bloch KV; da Rocha Nogueira A
    J Clin Epidemiol; 2009 Jul; 62(7):745-51. PubMed ID: 19128937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical relevance of office underestimation of usual blood pressure in treated hypertension.
    Schillaci G; Verdecchia P; Sacchi N; Bruni B; Benemio G; Pede S; Porcellati C
    Am J Hypertens; 2000 May; 13(5 Pt 1):523-8. PubMed ID: 10826404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.
    Okin PM; Hille DA; Larstorp AC; Wachtell K; Kjeldsen SE; Dahlöf B; Devereux RB
    Hypertension; 2015 Aug; 66(2):368-73. PubMed ID: 26056336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Managing hypertension in patients with chronic kidney disease - implications of the SPRINT study].
    Wojtaszek E; Głogowski T
    Wiad Lek; 2016; 69(5):742-744. PubMed ID: 28033599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.